ESTRO 2024 - Abstract Book

S300

Brachytherapy - Head & neck, skin, eye

ESTRO 2024

Figure 1. Visual impairment (ICD-11) in first five years of follow-up

Figure 2. Relation between tumour localization and post-treatment visual acuity change

Conclusion:

Local control and eye preservation rates after Ruthenium-106 brachytherapy are high. Visual acuity decline in the first five years after treatment is gradual and continuous, which fits the late effect of radiation therapy.